CIDRAP newsletters options
The report seeks to bridge the gap between current practice and the need to protect health workers.
The Food and Drug Administration (FDA) today said that it's revising a policy that aimed to accelerate the availability of COVID-19 antibody tests in the wake of reports that some companies have been marketing fraudulent tests.
Spain, the world's second hardest-hit country after the US, is taking cautious steps to ease its 7-week lockdown, while the US CDC launches a gene tracking consortium to help with response.
COVID-19 meat plant outbreaks have been noted in at least 5 Midwestern states.
Among the challenges highlighted in the report are limited data and lack of timely information.
Experts urge the WHO to develop guidance for the gradual return of passenger travel.
The Global Antibiotic Research and Development Partnership (GARDP) this week announced a partnership with Venatorx Pharmaceuticals to accelerate development of an investigational beta-lactam/beta-lactamase inhibitor combination for treating multidrug-resistant hospital infections.
Though many organization have published guidance on the best way forward during this COVID-19 pandemic, the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota saw a need for recommendations based on current realities and restrictions, not on technology such as widespread testing that may one day be in place.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The study provides clear evidence of the power of childhood vaccines on reducing the antibiotic resistance burden.
The UK will release a plan to begin loosening restrictions next week.
The opening of states is now in the hands of governors.
COVID-19 infected and killed more people in poor, ethnically diverse areas than in affluent, less diverse ones.
An international team of experts has published guidelines in CMAJ on treating COVID-19 patients that include "weak" recommendations for using corticosteroids in patients with acute respiratory distress syndrome (ARDS) and against using corticosteroids for patients without ARDS, convalescent plasma in patients with severe disease, and antiviral drugs in general.
As many as 9,000 additional deaths in the country could be attributed to COVID-19.
A study involving patients in China found a 2.4-times-higher death rate in men than in women.
A Chinese study, however, finds the drug not effective against serious disease.
Niger has recorded a 12.6% case-fatality rate, which approaches Italy's 13.1%.
The Democratic Republic of Congo (DRC) reported one more Ebola infection, raising the number of recent cases in Beni to seven.
The patient is a 39-year-old woman who had been in isolation since her daughter died from Ebola on April 20, Reuters reported yesterday. Her illness raises the outbreak total to 3,462, including 2,267 deaths, according to the World Health Organization (WHO) online dashboard.
Five COVID-19 patients in their 30s and 40s had large-vessel ischemic strokes from Mar 23 to Apr 7 in a New York City health system, more than five times what the system had been seeing every 2 weeks in the past year, according to a research letter published yesterday in the New England Journal of Medicine.
